You are here

Novo Nordisk

Inside the GLP-1 'price war'

Beckers Hospital Review

Tue, 09/24/24 - 11:52 am

U.S. Senator Sanders says pharmacy middlemen commit to expanding weight-loss drug coverage if prices cut

Reuters

Tue, 09/24/24 - 11:40 am

Novo says Ozempic to be eligible for US price negotiations in less than a year

Reuters

Mon, 09/23/24 - 10:27 pm

Novo Nordisk faces US congressional grilling over price of weight loss drugs

Reuters

Mon, 09/23/24 - 09:49 am

Novo obesity prospect linked to ‘mild to moderate neuropsychiatric side effects’ in phase 2

Fierce Biotech

Fri, 09/20/24 - 11:30 am

clinical trials

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

Reuters

Thu, 09/19/24 - 09:16 pm

heart failure with preserved ejection fraction

Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver

Fierce Biotech

Wed, 09/18/24 - 01:23 pm

NanoVation Therapeutics

genetic medicine

US Senator Sanders says generic drugmakers could sell Ozempic for less than $100/month

Reuters

Tue, 09/17/24 - 11:11 pm

Obesity pill race heats up as Novo, Roche and Terns share data

BioSpace

Tue, 09/17/24 - 11:22 am

Terns Pharmaceuticals

clinical trials

Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial

Fierce Biotech

Wed, 09/11/24 - 11:53 am

clinical trials

Study backs role of Novo Nordisk obesity drug in children

Pharmaphorum

Wed, 09/11/24 - 11:36 am

clinical trials

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

Forbes

Thu, 09/5/24 - 10:29 pm

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

Tue, 09/3/24 - 05:58 pm

Novo Nordisk's Ozempic shortage expected to continue into Q4

Reuters

Mon, 09/2/24 - 12:19 pm

Novo builds heart failure case for semaglutide

BioPharma Dive

Fri, 08/30/24 - 11:31 am

cardiovascular disease

Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145B Annually: Study

BioSpace

Tue, 08/27/24 - 11:32 am

cardiovascular disease

Ozempic on Wall Street's list for 2027 Medicare drug negotiations

Reuters

Fri, 08/23/24 - 10:59 am

Does Ozempic increase the risk of suicidal thoughts? A new study muddles the picture

Stat

Tue, 08/20/24 - 11:11 am

suicidal ideation

Novo Nordisk to build $220 mln raw materials plant in Denmark

Reuters

Fri, 08/16/24 - 11:20 am

Novo Nordisk Pharmatech

drug manufacturing

Pages